FDA enhances oversight of postmarket drug safety

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1400卷 / 1期

关键词：

Public Communication; Safety Communication; Safety Programme; Comprehensive Plan; Scientific Tool;

D O I：

10.2165/00128415-201214000-00003

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[1] US FDA to create new Drug Safety Oversight Board
[J]. Reactions Weekly, 2005, 1039 (1) : 3 - 3
[2] IOM Advises FDA on Ethics in Postmarket Safety Trials
Kuehn, Bridget M.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (06): : 627 - 627
[3] The Complications of Controlling Agency Time Discretion: FDA Review Deadlines and Postmarket Drug Safety
Carpenter, Daniel
Chattopadhyay, Jacqueline
Moffitt, Susan
Nall, Clayton
[J]. AMERICAN JOURNAL OF POLITICAL SCIENCE, 2012, 56 (01) : 98 - 114
[4] Postmarket safety events common after FDA approval
[J]. Reactions Weekly, 2017, 1652 (1) : 11 - 11
[5] Report hits FDA to revamp safety oversight
Finkelstein, Joel B.
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (13) : 884 - 885
[6] FDA bioproduct oversight shifts to drug division
Wong, JF
[J]. GENETIC ENGINEERING NEWS, 2002, 22 (17): : 55 - +
[7] FDA Realigns Drug Inspection and Manufacturing Oversight
Wechsler, Jill
[J]. BIOPHARM INTERNATIONAL, 2014, 27 (12) : 8 - +
[8] Advocates Call for FDA to Take Tougher Stance on Postmarket Safety Studies
Kuehn, Bridget M.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (15): : 1639 - +
[9] Enhancing Regulatory Decision Making for Postmarket Drug Safety
Ahuja, Vishal
Alvarez, Carlos A.
Birge, John R.
Syverson, Chad
[J]. MANAGEMENT SCIENCE, 2021, 67 (12) : 7493 - 7510
[10] DRUG SAFETY AND FDA
PISANI, JM
[J]. FOOD DRUG COSMETIC LAW JOURNAL, 1966, 21 (02): : 68 - 77

← 1 2 3 4 5 →